Trial intelligence / Profile preview

Local gentamicin injection for infection prevention in open tibial fractures

TCTR20170625002Recruiting

Sponsor
Hatyai Hospital
Start
Oct 2017
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Randomised trial of gentamicin in tibia fracture and surgical site infection (SSI) (2 arms), sponsored by Hatyai Hospital. Primary endpoint: Infection rate at fracture site. Started Oct 2017; status: recruiting.

02

Drugs

gentamicin
03

Conditions

tibia fracturesurgical site infection (SSI)

Beyond the preview

Go deeper on TCTR20170625002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170625002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call